In routine sensitivity testing by the disc diffusion method, one member for each group of related antibiotics is chosen to represent the group. Each new antibacterial drug is evaluated with respect to its previous antibiotic class disc. In this study, trimethoprim combined with sulphadiazine in the ratio 1:4 was compared when combined with sulpha-methoxazole in the ratio 1:20. Trimethoprim inhibited 86% of the bacterial strains tested at ≤4μg/ml and the sulphonamides 50% of the strains at ≤64 μg/ml. Regression line analysis showed that in sensitivity testing to trimethoprim alone discs with 5 μgcan be used. Trimethoprim combined with sulphamethoxazole or sulphadiazine inhibited 84% respectively 91% of the strains at 0.5–8 μg/ml. Trimethoprim combined with either sulphon-amide produced superimposable regression lines. Therefore, sensitivity testing to trimethoprim/sulphadiazine can be performed by using discs with trimethoprim/sulphamethoxazole and the inhibition zone ≥ 15 mm denotes susceptibility in the treatment of lower urinary tract infections.

Keywords:
Susceptibility testing, Regression lines, Sulphonamides, TMP, TMP-SMZ, TMP-SDZ
This content is only available via PDF.
© 1980 S. Karger AG, Basel
1980
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.